Evidence map›Paper›PMID 30488346›Full record

ArticlePsychopharmacology2019

Effects of a histone deacetylase 3 inhibitor on extinction and reinstatement of cocaine self-administration in rats.

Leah N Hitchcock, Jonathan D Raybuck, Marcelo A Wood, K Matthew Lattal

Abstract read
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Epigenetic Effects of Addictive Drugs in the Nucleus Accumbens.Frontiers in molecular neuroscience · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Epigenetic Mechanisms in Drug Relapse.Biological psychiatry · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Leah N HitchcockDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
Jonathan D RaybuckDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
Marcelo A WoodDepartment of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, USA.
K Matthew LattalDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA. lattalm@ohsu.edu.
Oregon Health & Science University · USUniversity of California, Irvine · US

Funding

Traditional Service Core [Translational Service Core (TSC)]P50DA018165 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PHILLIPS, TAMARA J. · 2006 to 2016
$13.0M
BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
Behavioral and Epigenetic Mechanisms in Extinction of Cocaine-Induced MemoriesR01DA025922 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI LATTAL, K MATTHEW, WOOD, MARCELO ANDRES · 2008 to 2018
$5.1M
Opioid Sensitive GABA inputs to the Ventral MidbrainR01DA034388 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2012 to 2016
$967k
National Institute on Drug Abuse (US) R01 025922NIDA NIH HHS P50 DA018165NIDA NIH HHS R01 DA025922NIDA NIH HHS R01 DA034388NIDA NIH HHS T32 DA007262NIDA NIH HHS T32DA007262U.S. Department of Defense (US) W81XWH-12-2-0048
6 · The paper itself

Abstract

rationaleA challenge in treating substance use disorder is that successful treatment often does not persist, resulting in relapse and continued drug seeking. One approach to persistently weaken drug-seeking behaviors is to pair exposure to drug-associated cues or behaviors with delivery of a compound that may strengthen the inhibition of the association between drug cues and behavior.

objectivesWe evaluated whether a selective histone deacetylase 3 (HDAC3) inhibitor could promote extinction and weaken contextual control of operant drug seeking after intravenous cocaine self-administration.

methodsMale Long-Evans rats received a systemic injection of the HDAC3 inhibitor RGFP966 either before or immediately after the first extinction session. Persistence of extinction was tested over subsequent extinction sessions, as well as tests of reinstatement that included cue-induced reinstatement, contextual renewal, and cocaine-primed reinstatement. Additional extinction sessions occurred between each reinstatement test. We also evaluated effects of RGFP966 on performance and motivation during stable fixed ratio operant responding for cocaine and during a progressive ratio of reinforcement.

resultsRGFP966 administered before the first extinction session led to significantly less responding during subsequent extinction and reinstatement tests compared to vehicle-injected rats. Follow-up studies found that these effects were not likely due to a performance deficit or a change in motivation to self-administer cocaine, as injections of RGFP966 had no effect on stable responding during a fixed or progressive ratio schedule. In addition, RGFP966 administered just after the first extinction session had no effect during early extinction and reinstatement tests, but weakened long-term responding during later extinction sessions.

conclusionsThese results suggest that a systemic injection of a selective HDAC3 inhibitor can enhance extinction and suppress reinstatement after cocaine self-administration. The finding that behavioral and pharmacological manipulations can be combined to decrease drug seeking provides further potential for treatment by epigenetic modulation.

Indexed as

AcrylamidesAnimalsAssociation LearningCocaineCocaine-Related DisordersConditioning, OperantCuesDrug-Seeking BehaviorExtinction, PsychologicalHistone Deacetylase 3Histone Deacetylase InhibitorsHistone DeacetylasesMalePhenylenediaminesRatsRats, Long-EvansAcrylamidesCocaineHistone Deacetylase 3Histone Deacetylase InhibitorsHistone DeacetylasesPhenylenediaminesRGFP966EpigeneticsExtinctionHistone acetylationIntravenous cocaineLong-Evans rats

Identifiers

PMID30488346
PMCPMC6459190
OpenAlexW2903280192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.